Description: Cure Pharmaceutical Holding Corp., formerly Makkanotti Group Corp., is a specialty pharmaceutical and bioscience company with a focus in drug delivery technologies. The Company offers drug delivery technologies to develop and commercialize new applications of therapeutics through oral thin film (OTF) through its CureFilm technology, as well as through transdermal applications. Its micro encapsulation of drug actives in its CureFilm technology allows for a higher volume of an active and if required, multiple actives to be produced on a single oral thin film strip. It is focused on both the human and veterinary prescription, over-the-counter (OTC) and nutraceutical markets. It offers various types of CureFilm dietary supplement products, which are being Commercialized, such as MacuStrip Vitamin complex (eye health product), ID Life Sleep melatonin and Electrolyte (Adult and Pediatric), and are in development, which includes Aspirin, Loratadine, Tadalifil, Sildenafil and Loperamide.
Home Page: www.curepharmaceutical.com
1620 Beacon Place
Oxnard,
CA
93033
United States
Phone:
805 824 0410
Officers
| Name | Title |
|---|---|
| Mr. Robert Davidson | CEO, Founder and Pres & Chairman |
| Mr. Michael Redard CFO, CPA | CFO & Sec. |
| Mr. Mark Udell CPA, CPA | Chief Accounting Officer & Treasurer |
| Mr. Bhaumik Patel | Director of New Technologies |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.8469 |
| Price-to-Sales TTM: | 1.8358 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 28 |